A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a ...
TipRanks on MSN
Veracyte announces results from BALANCE trial of PAM50
Veracyte (VCYT) announces randomized biomarker BALANCE trial finds that the PAM50 molecular signature predicts which patients with recurrent ...
The article states that prior convictions can be used to challenge a witness’s credibility under CPLR 4513, but courts ...
Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may ...
New research in cerebellar ataxia challenges current guidelines that focus on balance training, finding that aerobic workouts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback